Copyright
©The Author(s) 2022.
World J Clin Oncol. May 24, 2022; 13(5): 352-365
Published online May 24, 2022. doi: 10.5306/wjco.v13.i5.352
Published online May 24, 2022. doi: 10.5306/wjco.v13.i5.352
Table 3 Summary characteristics of by surgery types (total 219 patients)
| Factor | Group | None | Transplant | Wedge or segmental resection | Lobectomy | Extended lobectomy | P value |
| n | Total 219 | 108 | 19 | 39 | 42 | 11 | |
| Alive | Total 67 | 10 (9.3) | 7 (36.8) | 23 (59.0) | 21 (50.0) | 6 (54.6) | < 0.001 |
| Age group (%) | ≤ 19 | 18 (16.7) | 6 (31.6) | 15 (38.5) | 16 (38.1) | 7 (63.6) | < 0.001 |
| 20-59 | 54 (50.0) | 13 (68.4) | 17 (43.6) | 23 (54.8) | 4 (36.4) | ||
| ≥ 60 | 36 (33.3) | 0 (0) | 7 (18.0) | 3 (7.1) | 0 (0) | ||
| Sex (%) | Male | 70 (64.8) | 12 (63.2) | 27 (69.2) | 21 (50.0) | 7 (63.6) | 0.43 |
| Stages (%) | I | 22 (20.4) | 4 (21.1) | 19 (48.7) | 15 (35.7 ) | 2 (18.2) | < 0.001 |
| II | 3 (2.8) | 0 (0) | 8 (20.5) | 5 (11.9) | 2 (18.2) | ||
| III | 24 (22.2) | 10 (52.6) | 9 (23.1) | 13 (31.0) | 4 (36.4) | ||
| IV | 43 (39.8) | 4 (21.1) | 3 (7.7) | 8 (19.1) | 2 (18.2) | ||
| Unknown | 16 (14.8) | 1 (5.3) | 0 (0) | 1 (2.4) | 1 (9.1) | ||
| Race (%) | API | 13 (12.0) | 1 (5.3) | 3 (7.7) | 3 (7.1) | 1 (9.1) | 0.28 |
| Black | 17 (15.7) | 2 (10.5) | 2 (5.1) | 6 (14.3) | 0 (0) | ||
| Hispanic | 29 (26.9) | 4 (21.1) | 6 (15.4) | 8 (19.1) | 5 (45.5) | ||
| White | 49 (45.4) | 12 (63.2) | 28 (71.8) | 25 (59.5) | 5 (45.5) | ||
| Income (%) | < $55000 | 29 (26.9) | 3 (15.8) | 12 (30.8) | 8 (19.1) | 1 (9.1) | 0.22 |
| $55000-70000 | 41 (38.0) | 8 (42.1) | 15 (38.5) | 13 (31.0) | 8 (72.7) | ||
| > $70000 | 38 (35.2) | 8 (42.1) | 12 (30.8) | 21 (50.0) | 2 (18.2) | ||
| Lymph nodes status (%) | N0 | 64 (59.3) | 12 (63.2) | 32 (82.1) | 24 (57.1) | 6 (54.6) | 0.007 |
| N1 | 25 (23.2) | 6 (31.6) | 7 (18.0) | 17 (40.5) | 4 (36.4) | ||
| Nx | 19 (17.6) | 1 (5.3) | 0(0) | 1 (2.4) | 1 (9.1) | ||
| Metastasis status (%) | M0 | 56 (52.9) | 15 (79.0) | 36 (92.3) | 34 (81.0) | 8 (72.7) | < 0.001 |
| M1 | 43 (39.8) | 4 (21.1) | 3 (7.7) | 8 (19.1) | 2 (18.2) | ||
| Mx | 9 (8.3) | 0 (0) | 0 (0) | 0 (0) | 1 (9.1) | ||
| Population (%) | ≥ 1 million | 76 (70.4) | 13 (68.4) | 21 (53.9) | 24 (57.1) | 7 (63.6) | 0.32 |
| Others | 32 (29.7) | 6 (31.6) | 18 (46.2) | 18 (42.9) | 4 (36.4) | ||
| Size (%) | ≤ 50 mm | 18 (16.7) | 1 (5.3) | 12 (30.8) | 6 (14.3) | 1 (9.1) | < 0.001 |
| 51-100 mm | 25 (23.2) | 5 (26.3) | 15 (38.5) | 14 (33.3) | 3 (27.3) | ||
| ≥ 100 mm | 37 (34.3) | 11 (57.9) | 10 (25.6) | 21 (50.0) | 7 (63.6) | ||
| Unknown | 28 (25.9) | 2 (10.5) | 2 (5.1) | 1 (2.4) | 0 (0) |
- Citation: Sempokuya T, Forlemu A, Azawi M, Silangcruz K, Khoury N, Ma J, Wong LL. Survival characteristics of fibrolamellar hepatocellular carcinoma: A Surveillance, Epidemiology, and End Results database study. World J Clin Oncol 2022; 13(5): 352-365
- URL: https://www.wjgnet.com/2218-4333/full/v13/i5/352.htm
- DOI: https://dx.doi.org/10.5306/wjco.v13.i5.352